Brevan Howard Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Buy |
+21,814
| New | +$5.26M | 0.03% | 294 |
|
|
2024
Q4 | – | Sell |
-11,083
| Closed | -$3.71M | – | 1024 |
|
|
2024
Q3 | $3.71M | Buy |
11,083
+8,825
| +391% | +$2.95M | 0.03% | 117 |
|
|
2024
Q2 | $617K | Buy |
2,258
+1,403
| +164% | +$383K | 0.01% | 486 |
|
|
2024
Q1 | $296K | Sell |
855
-552
| -39% | -$191K | ﹤0.01% | 614 |
|
|
2023
Q4 | $454K | Buy |
+1,407
| New | +$454K | 0.01% | 478 |
|